Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PAVmed Inc
PAVM | US
9.00
USD-0.17
-1.85%
PAVM | US
About PAVmed Inc
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
24/04/2026
Close
9.00
Open
9.10
High
9.20
Low
9.00
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX a patented single-use disposable and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure an esophageal ablation device to treat dysplastic BE; PortIO an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York New York.
View LessPAVM | US
Risk
64.0
Sharpe
-0.52
Luna's Score
43/100
Recommendation
Sell
Luna says (PAVM | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
41.6%1 month
64.0%3 months
79.2%6 months
167.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
7.42
Debt to equity
-0.68
Debt to assets
1.27
Ent. to EBITDA
-0.33
Ent. to rev.
9.93
PEG
-
Other Fundamentals
EBITDA
-57.28M
MarketCap
89.55M
MarketCap(USD)
89.55M
Div. yield
-
Op. margin
-1.40K
Erngs. growth
-
Rev. growth
489.80
Ret. on equity
-1.36K
Short ratio
2.59
Short perc.
2.97
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.75
Range1M
1.73
Range3M
5.03
Volumes: Market Activity
Rel. volume
1.15
Price X volume
128.21K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.33 | - | Cheaper |
| Ent. to Revenue | 9.93 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 7.42 | 6.21 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 79.17 | - | Riskier |
| Debt to Equity | -0.68 | -145.53 | Expensive |
| Debt to Assets | 1.27 | 0.35 | Expensive |
| Market Cap | 89.55M | - | Emerging |
